Luis A. Rivas
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Molecular switches meet multivalency: Antimicrobial activity of multimeric peptide assemblies from the pneumococcal LytA autolysin.
Journal: International journal of biological macromolecules
Published: March 03, 2026
Human Small Airway Epithelia Reveal Dichloroacetate as a Broad-Spectrum Antiviral Against Respiratory Viruses.
Journal: International journal of molecular sciences
Published: September 05, 2025
Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis.
Journal: PLoS pathogens
Published: June 05, 2025
AI Predictive Model of Mortality and Intensive Care Unit Admission in the COVID-19 Pandemic: Retrospective Population Cohort Study of 12,000 Patients.
Journal: Journal of medical Internet research
Published: January 17, 2025
Effect of the aggregated protein dye YAT2150 on Leishmania parasite viability.
Journal: Antimicrobial agents and chemotherapy
Published: February 13, 2024
In Vitro Evaluation of Aerosol Therapy with Pentamidine-Loaded Liposomes Coated with Chondroitin Sulfate or Heparin for the Treatment of Leishmaniasis.
Journal: Pharmaceutics
Published: February 28, 2023
Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3.
Journal: Biomedicines
Published: April 05, 2022
Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis.
Journal: Bioorganic chemistry
Published: February 07, 2022
Last Updated: 09/26/2026